Motivational Interviewing Aids Weight Loss in Primary Care

This article originally appeared here.
Share this content:
Motivational Interviewing Aids Weight Loss in Primary Care
Motivational Interviewing Aids Weight Loss in Primary Care

MONDAY, April 6, 2015 (HealthDay News) -- Motivational interviewing can help patients lose weight in a primary care setting, according to a review published in the April issue of Obesity Reviews.

Rachel D. Barnes, Ph.D., and Valentina Ivezaj, Ph.D., from the Yale University School of Medicine in New Haven, Conn., conducted a systematic review of 24 randomized controlled trials to examine motivational interviewing for weight loss among adults in primary care. Motivational interviewing interventions were generally provided individually and compared with usual care. Adequate information regarding motivational interviewing treatment fidelity was provided by few studies.

The researchers found that significant weight loss was reported in nine studies (37.5 percent) at post-treatment assessment for the motivational interviewing versus the control condition. Achievement of at least 5 percent loss of initial body weight was reported in 13 studies (54.2 percent).

"There is potential for motivational interviewing to help primary care patients lose weight," the authors write. "Conclusions, however, must be drawn cautiously as more than half of the reviewed studies showed no significant weight loss compared with usual care and few reported motivational interviewing treatment fidelity."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »